Reuters logo
BRIEF-BioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company
2016年11月21日 / 下午12点42分 / 1 年前

BRIEF-BioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company

Nov 21 (Reuters) - Bioline Rx Ltd :

* BioLine RX Ltd - in addition to des, biolinerx intends to explore potential use of bl-1230 in systemic inflammatory conditions

* Press release - bioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below